Table: Noile-Immune Biotech -2025 parent results

Noile-Immune Biotech

13/02/2026 07:05

Feb 13 (Reuters)- 
          Noile-Immune Biotech Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2025    Dec 31, 2024   Dec 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           5 mln           7 mln                                
               (-34.1 pct)     (-97.6 pct)                             
  Operating   loss 797 mln      loss 1.07                              
  Recurring   loss 791 mln    loss 962 mln                             
  Net         loss 793 mln    loss 964 mln                             
  EPS        loss 18.33 yen  loss 22.28 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - Noile-Immune Biotech Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T